Acetal-derivatized dextran:: An acid-responsive biodegradable material for therapeutic applications

被引:395
作者
Bachelder, Eric M. [1 ]
Beaudette, Tristan T. [1 ]
Broaders, Kyle E. [1 ]
Dashe, Jesse [1 ]
Frechet, Jean M. J. [1 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
关键词
D O I
10.1021/ja803947s
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dextran, a biocompatible, water-soluble polysaccharide, was modified at its hydroxyls with acetal moieties such that it became insoluble in water but freely soluble in common organic solvents enabling its use in the facile preparation of acid-sensitive microparticles. These particles degrade in a pH-dependent manner: FITC-dextran was released with a half-life at 37 degrees C of 10 h at pH 5.0 compared to a half-life of approximately 15 days at pH 7.4. Both hydrophobic and hydrophilic cargoes were successfully loaded into these particles using single and double emulsion techniques, respectively. When used in a model vaccine application, particles loaded with the protein ovalbumin (OVA) increased the presentation of OVA-derived peptides to CD8(+) T-cells 16-fold relative to OVA alone. Additionally, this dextran derivative was found to be nontoxic in preliminary in vitro cytotoxicity assays. Owing to its ease of preparation, processability, pH-sensitivity, and biocompatibility, this type of modified dextran should find use in numerous drug delivery applications.
引用
收藏
页码:10494 / +
页数:3
相关论文
共 25 条
  • [21] Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
    Sengupta, S
    Eavarone, D
    Capila, I
    Zhao, GL
    Watson, N
    Kiziltepe, T
    Sasisekharan, R
    [J]. NATURE, 2005, 436 (7050) : 568 - 572
  • [22] Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells
    Solbrig, C. M.
    Saucier-Sawyer, J. K.
    Cody, V.
    Saltzman, W. M.
    Hanlon, D. J.
    [J]. MOLECULAR PHARMACEUTICS, 2007, 4 (01) : 47 - 57
  • [23] Acid-degradable particles for protein-based vaccines:: Enhanced survival rate for tumor-challenged mice using ovalbumin model
    Standley, SM
    Kwon, YJ
    Murthy, N
    Kunisawa, J
    Shastri, N
    Guillaudeu, SJ
    Lau, L
    Fréchet, JMJ
    [J]. BIOCONJUGATE CHEMISTRY, 2004, 15 (06) : 1281 - 1288
  • [24] Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase
    Sun-Wada, GH
    Wada, Y
    Futai, M
    [J]. CELL STRUCTURE AND FUNCTION, 2003, 28 (05) : 455 - 463
  • [25] TIMED-RELEASE DEPOT FOR ANTICANCER AGENTS
    YOLLES, S
    LEAFE, TD
    MEYER, FJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (01) : 115 - 116